Stay updated on Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now shows revision v3.5.5, replacing v3.5.4, indicating a small backend update to the page's versioning.
    Difference
    0.1%
    Check dated 2026-06-05T08:47:19.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The revision tag was updated from v3.5.3 to v3.5.4, indicating a small maintenance update to the page's documentation/versioning. It does not change trial information or user-facing content.
    Difference
    0.1%
    Check dated 2026-05-14T23:17:09.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.3, replacing v3.5.2, indicating a new version of the page.
    Difference
    0.1%
    Check dated 2026-04-30T16:53:27.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:55:18.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Added the term Hepatocellular carcinoma and a new 'Genetic and Rare Diseases Information Center' resource; updated the site revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T18:02:32.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Page version updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T16:29:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.